1. Scrip
  2. >>Business
  3. >>Strategy

AstraZeneca Q3 Sales Rise 'Is Milestone', CEO Soriot 'Not Leaving'

 
• By Sten Stovall

AstraZeneca's third-quarter results show it has emerged from a long decline and returned to growth, fuelled by new products and pipeline, the UK pharma's CEO Pascal Soriot told reporters, adding that he's having too much fun turning the group around to leave any time soon.

AstraZeneca
AstraZeneca Returns to Sales Growth; New Medicines and Emerging Markets Lead the Way • Source: Shutterstock

Marking a crucial milestone in its turnaround plans, AstraZeneca PLC in the third quarter saw product sales growth for the first time since 2014, a trend the group's CEO Pascal Soriot said will only strengthen, backed by new product launches and helped by the absence of fresh patent expiries of aging blockbusters.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business